Search Press releases Keywords From To 18 Aug 2016 Transparency notification Read More 14 Aug 2016 U.S. District Court confirms validity of patent for UCB's Vimpat® Read More 27 Jul 2016 UCB continues to deliver on its growth strategy Read More 22 Jul 2016 UCB and Amgen submit biologics license application for Romosozumab to the U.S. FDA Read More 4 Jul 2016 UCB and Daiichi Sankyo announce Japanese approval of lacosamide (brand name VIMPAT®) as adjunctive therapy in the treatment of partial-onset seizures in adult patients with epilepsy Read More 9 Jun 2016 UCB’s bimekizumab demonstrates positive results in early development in patients with psoriatic arthritis Read More Pagination First page Previous page Previous … Page 89 Page 90 Page 91 Page 92 Current page 93 Page 94 Page 95 Page 96 Page 97 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
